Abstract:Substance use disorders (SUDs) induce widespread molecular dysregulation in the nucleus accumbens (NAc), a brain region pivotal for coordinating motivation and reward. These molecular changes are thought to support lasting neural and behavioral disturbances that promote drug-seeking in addiction. However, different drug classes exert unique influences on neural circuits, cell types, physiology, and gene expression despite the overlapping symptomatology of SUDs. To better understand common and divergent molecular mechanisms governing SUD pathology, our goal was to survey cell-type-specific restructuring of the NAc transcriptional landscape in after psychostimulant or opioid exposure. We combined fluorescence-activated nuclei sorting and RNA sequencing to profile NAc D1 and D2 medium spiny neurons (MSNs) across cocaine and morphine exposure paradigms, including initial exposure, prolonged withdrawal after repeated exposure, and re-exposure post-withdrawal. Our analyses reveal that D1 MSNs display many convergent transcriptional responses across drug classes during exposure, whereas D2 MSNs manifest mostly divergent responses between cocaine and morphine, with morphine causing more adaptations in this cell type. Utilizing multiscale embedded gene co-expression network analysis (MEGENA), we discerned transcriptional regulatory networks subserving biological functions shared between cocaine and morphine. We observed largely integrative engagement of overlapping gene networks across drug classes in D1 MSNs, but opposite regulation of key D2 networks, highlighting potential therapeutic gene network targets within MSNs. These studies establish a landmark, cell-type-specific atlas of transcriptional regulation induced by cocaine and by morphine that can serve as a foundation for future studies towards mechanistic understanding of SUDs. Our findings, and future work leveraging this dataset, will pave the way for the development of targeted therapeutic interventions, addressing the urgent need for more effective treatments for cocaine use disorder and enhancing the existing strategies for opioid use disorder.

Cell Type-Specific Whole-Genome Landscape of ΔFOSB Binding in the Nucleus Accumbens After Chronic Cocaine Exposure

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Chronic Cocaine-Regulated Epigenomic Changes in Mouse Nucleus Accumbens.

Cocaine-Induced Chromatin Modifications Associate with Increased Expression and Three-Dimensional Looping of Auts2.

CREB Binding at the Zfp189 Promoter Within Medium Spiny Neuron Subtypes Differentially Regulates Behavioral and Physiological Adaptations over the Course of Cocaine Use.

Transcription Factor E2F3a in Nucleus Accumbens Affects Cocaine Action Via Transcription and Alternative Splicing

Cocaine Dynamically Regulates Heterochromatin And Repetitive Element Unsilencing In Nucleus Accumbens

A novel role for E2F3b in regulating cocaine action in the prefrontal cortex

Locus-specific Epigenetic Remodeling Controls Addiction- and Depression-Related Behaviors

Role of Tet1 and 5-Hydroxymethylcytosine in Cocaine Action

Long Read, Isoform Aware Sequencing of Mouse Nucleus Accumbens after Chronic Cocaine Treatment.

Bidirectional Synaptic Structural Plasticity after Chronic Cocaine Administration Occurs Through Rap1 Small GTPase Signaling.

Fos Regulates Neuronal Activity in the Nucleus Accumbens

Cell type–specific epigenetic priming of gene expression in nucleus accumbens by cocaine

c-Fos is an intracellular regulator of cocaine-induced long-term changes.

C-Fos Facilitates The Acquisition And Extinction Of Cocaine-Induced Persistent Changes

Cell-Type-Specific Regulation of Cocaine Reward by the E2F3a Transcription Factor in Nucleus Accumbens

Cocaine, via ΔFosB, remodels gene expression and excitability in ventral hippocampus

Cocaine taking and craving produce distinct transcriptional profiles in dopamine neurons

Transcriptome Sequencing Reveals Candidate Nf-Kappa B Target Genes Involved In Repeated Cocaine Administration